Left Caputo fractional ‖⋅‖∞-Landau inequalities

G. Anastassiou

DOI: https://doi.org/10.1016/j.aml.2011.01.041

IF: 4.294

2011-07-01

Applied Mathematics Letters

Abstract:

What problem does this paper attempt to address?

Primary Leiomyosarcoma of the Thyroid Gland: A Rare Case Report and Literature Review

Ziwei Huang,Xiping Yu,Jialang Yan,Yuanxiao Yin,Junhao Li,Yixiong Zheng

DOI: https://doi.org/10.1016/j.ijscr.2024.109773

2024-01-01

International Journal of Surgery Case Reports

Abstract:IntroductionPrimary thyroid leiomyosarcoma is an extremely rare soft tissue sarcoma, characterized by high malignancy and poor prognosis. Currently, only 13 cases of primary thyroid leiomyosarcoma have been described in the medical literature (limited to English).Case presentationA 76-year-old female presented with a giant neck mass. Physical examination revealed a large, firm mass in the left thyroid gland. No symptoms such as hoarseness or dysphagia were noted at the time of presentation. The patient underwent unilateral thyroidectomy and cervical lymph node dissection.Clinical discussionPathologic findings revealed a low-grade sarcoma with spindle-shaped tumor cells in an interwoven, sheet-like distribution. Immunohistochemistry showed positivity for desmin, SMMHC, STAT6, CK19, and Galectin3, but negativity for S-100, MyoD1, CD34, CK (AE1/AE3), CD117, and CD56. The findings were consistent with thyroid leiomyosarcoma.ConclusionThe treatment of primary thyroid LMS presents challenges due to its atypical symptoms and high malignance, highlighting the imperative for further exploration of therapeutic strategies to improve the outcomes.
[Carcinoma Showing Thymus-Like Differentiation of the Thyroid: a Study of 2 Cases].

Zhao-Ming Wang,Ke Sun,Yi Pan,Guo-Ping Ren

DOI: https://doi.org/10.3760/j.issn:0529-5807.2005.11.007

2005-01-01

Abstract:OBJECTIVE:To describe the pathologic features and differential diagnosis of carcinoma showing thymus-like differentiation (CASTLE) of thyroid.METHODS:The clinical findings, morphologic features and immunohistochemistry (EnVision) of 2 cases of CASTLE were studied.RESULTS:Macroscopically, the tumor appeared as a hard grayish-white and slightly lobulated mass. Histologic examination revealed well-circumscribed islands of tumor cells associated with desmoplastic stroma. The tumor cells were polygonal to spindle in shape and contained lightly eosinophilic cytoplasm, oval nuclei and small distinct nucleoli. The nuclear atypia was mild to moderate and the mitotic count measured 1 to 2 per 10 high-power fields. Immunohistochemical study showed that the tumor cells expressed CD5 and CD117.CONCLUSIONS:CASTLE is a rare type of thyroid carcinoma with distinctive morphologic findings. It needs to be distinguished from undifferentiated thyroid carcinoma, squamous cell thyroid carcinoma, metastatic lymphoepithelioma-like carcinoma and follicular dendritic cell sarcoma. Immunohistochemical staining for CD5 and CD117 is helpful in confirming the diagnosis.
Primary Small Cell Cancer of Cervical Trachea: A Case Report and Literature Review

Jun Qiu,Wei Lin,Min-Li Zhou,Shui-Hong Zhou,Qin-Ying Wang,Yang-Yang Bao

2015-01-01

Abstract:Primary small cell carcinoma of trachea is even more uncommon and only a few cases have been reported. Our search revealed only 90 cases in the English-language literatures. Case report: we report a case of cervical tracheal small cell cancer. A 67-year-old male presented with over 2-month history of cough and dyspnea. CT and MRI revealed a 1.0 cm x 2.5 cm intraluminal, irregular soft tissue mass in the upper trachea, approximately 2.5 cm below the glottis. A bronchoscopic examination disclosed a large tumor in the cervical trachea and the lesion occupied more than 60% of the tracheal lumen. Cytological examination suggested some poorly differentiated carcinoma cells. The patient received concurrent chemoradiotherapyand did not perform surgery. One week after CCR, the patient occurred difficulty in breath and tracheal stent was implanted. The symptom was improved markedly. Four days after implant of tracheal stent, the patient presented irritable cough and hemoptysis. The amount of bleeding was about 300 ml. The hemorrhage stopped by treatment of vasoconstrictor and fresh plasma. However, two days later, hemoptysis was continuing even if treatment of vasoconstrictor and fresh plasma. The patient and relatives waived the further therapies. The patient died of massive hemoptysis one week out of hospital. Conclusions: The tracheal small cell cancer is rare. The optimal treatment is unclear. In general, the strategy is introduced concurrent chemoradiotherapy following as small cell lung cancer. In cervical trachea, we suggest that surgical resection should be performed followed by postoperative adjuvant therapy.
The Rate of Bromate Decomposition in the Simulated Human Stomach and Associated Studies

R. Bull

Abstract:In Part I, it expands the initial Phase I work by evaluating the roles of various co-constituents that could be present in drinking water or in stomach fluids to determine their affect on the rates of reaction in simulated gastric juice at low pH and in the presence of chloride and hydrogen sulfide. The issue being investigated was whether bromate could be decomposed to some degree in the stomach (and in other premetabolism segments such as liver and blood), and therefore reduce the amount that could ultimately reach target organs. If sufficient bromate could be reduced prior to reaching target organs, the actual risk at low environmentally relevant doses would be lower than predicted by the current risk calculation methodologies.
Diagnosis of medial tubercle fractures of the talar posterior process using oblique views.

N. Ebraheim,Vishwas Patil,N. Frisch,Xiaochen Liu

DOI: https://doi.org/10.1016/J.INJURY.2007.04.025

IF: 2.687

2007-11-01

Injury

Abstract:
Structure of testicular angiotensin-converting enzyme. A segmental mosaic isozyme.

Ravi S. Kumar,J. Kusari,S. Roy,R. Soffer,Ganes C. Sen

IF: 5.485

1989-10-05

Journal of Biological Chemistry

Abstract:The complete amino acid sequence of rabbit testicular angiotensin-converting enzyme has been deduced from the sequence of the corresponding cDNA clone. A protein of the expected molecular weight of 84,000 was translated in vitro from the mRNA encoded by this cDNA. All of the previously determined sequences of seven tryptic peptides from the enzyme are present in the deduced sequence, thus confirming the identity of the protein. From the deduced sequence it appears that the protein contains a signal peptide at the amino terminus and a hydrophobic anchoring domain near the carboxyl terminus. Northern analysis with oligonucleotide probes, whose sequences represented different regions of the cDNA, revealed not only the regions of extensive homology between the mRNAs encoding the testicular and the pulmonary isozymes but also a stretch of sequence near the 5' end unique to the testicular mRNA.
[Six cases of thymic carcinoma: a clinical review]

Yoshizumi Takemura,Tatsuya Yuba,Kenji Kono,Kunishige Hosogi,Shuji Osugi,Hiromi Kuwahara,Kazuhiro Nagata,Hidehiko Harada,Ichiro Yokomura,Yoshinobu Iwasaki

Abstract:Thymic carcinoma is rarer than thymoma and carries a very poor prognosis. No standard treatment has yet been established. Chemotherapy and radiation therapy are usually given to patients in whom surgery is not indicated. We clinically review six patients with thymic carcinoma (three men and three women) who were admitted to our hospital from 1992 through 2002. Their ages ranged from 56 to 81 years (median 70.5). Four patients had chest pain, two were unable to swallow, and in one, who was asymptomatic, the tumor was detected by chance. Histologically, five cases were squamous cell carcinomas, and one was a lymphoepithelioma-like carcinoma. Four of the six patients had distant metastasis at diagnosis. Only one patient was able to undergo surgery, two received radiation therapy alone, and three were administered chemoradiation. The response to the chemoradiation was progression of the disease in two patients and no change in one. The response to radiation therapy was partial response in one patient and no change in one. In summary, chest pain is the most common symptom of thymic carcinoma. A symptomatic case suggests a poor prognosis resulting from the clinical behavior of thymic carcinoma, such as early distant metastasis or direct invasion of surrounding organs. Histologically, squamous cell carcinoma is the most common, and thymic carcinoma appears to be generally resistant to chemotherapy and radiotherapy.
A basaloid carcinoma with multilocular thymic cyst mimicking a mediastinal teratoma

Chen Su,Xiaobo Zhu,Qiang Wang,Junjie Zhang

DOI: https://doi.org/10.1186/s13019-024-02712-z

2024-04-12

Journal of Cardiothoracic Surgery

Abstract:This case report details a rare thymic basaloid carcinoma initially misinterpreted as a mediastinal teratoma, underscoring the diagnostic challenges posed by such tumors. A 71-year-old female presented with an asymptomatic anterior mediastinal tumor discovered incidentally during a routine health examination. Surgical intervention, followed by pathological and immunohistochemical analysis including CK-pan, p63, p40, and CD117 molecules, led to a definitive diagnosis of basaloid carcinoma of the thymus. This case highlights the critical importance of differential diagnosis in mediastinal lesions, especially those presenting with multilocular thymic cysts on chest CT. The subxiphoid video-assisted thoracoscopic surgery enabled complete tumor resection with minimal trauma and favorable postoperative outcomes. The patient opted against further radiotherapy or chemotherapy and she has survived for over eight months without recurrence. This case report contributes to the growing understanding of thymic basaloid carcinoma, a rare and potentially aggressive thymic carcinoma subtype. It emphasizes the necessity for precise surgical techniques and enhanced diagnostic acumen among cardiothoracic surgeons and oncologists.

surgery,cardiac & cardiovascular systems
About thymic carcinomas: challenges in diagnosis and management

Mouna Mlika,Sadok Boudaya,Emna Braham,Fatma Chermiti,Ahmed Sayi,Adel Marghli,Faouzi El Mezni

DOI: https://doi.org/10.1177/0218492316640129

Abstract:Background: Thymic carcinomas are rare tumors with a challenging diagnosis. Our aim was to report our 17-year experience of these tumors and to highlight the challenges encountered and the main differential diagnoses ruled out. Methods: We studied 12 (92%) men and 1 (7.7%) woman with a mean age of 37 years (range 15-60 years). All patients were symptomatic, with chest pain representing the most frequent symptom. Radiology revealed anterior mediastinal masses in all cases, with either infiltration of the adjacent organs or pulmonary parenchymal metastases. Results: The diagnosis was made on surgical biopsies in 12 cases and a lymph node biopsy in one. Microscopic examination revealed squamous carcinoma in 3 cases, synovial sarcoma in 1, mucinous adenocarcinoma in 1, undifferentiated carcinoma in 2, clear cell carcinoma in 1, lymphoepithelioma-like carcinoma in 2, atypical carcinoid tumor in 2, and sarcomatoid carcinoma in 1. Total surgical resection was possible in one patient after neoadjuvant chemotherapy and radiotherapy. Follow-up was possible in only 6 patients, and the mean survival reached 13 months. Conclusion: In spite of the lack of follow-up information, this study demonstrates the poor outcome associated with these tumors and the need for standardized treatment.
Thymic carcinoid with multiple bone metastases: A case report

Chun-Qiao Chen,Ming-Yue Huang,Min Pan,Qiu-Qiu Chen,Fei-Fei Wei,Hui Huang

DOI: https://doi.org/10.12998/wjcc.v12.i13.2275

2024-05-06

World Journal of Clinical Cases

Abstract:BACKGROUND Thymic carcinoid (TC) is a rare entity among anterior mediastinal malignancies. TCs are neuroendocrine carcinomas that constitute approximately 2%–5% of all thymic epithelial tumors. CASE SUMMARY The study reported a rare TC with multiple bone metastases. A 77-year-old man presented with a 2-month history of lower back pain and weight loss of 5 kg. Magnetic resonance imaging scans revealed damage to the lumbar spine, sacrocaudal vertebrae and iliac crest, suggesting bone metastasis; computed tomography (CT) scan of the thorax showed a calcified anterior mediastinal mass; positron emission tomography-CT demonstrated multiple abnormal bone signals; and laboratory work-up showed no endocrine abnormalities. Fine-needle aspiration biopsy revealed predominantly single small, round to oval cells with scant cytoplasm and some loose clusters, suggesting endocrine manifestations. The pathological diagnosis was atypical carcinoid, which tend to originate from the thymus and was classified as intermediate-highly invasive. The patient underwent anlotinib-targeted therapy. Anlotinib (12 mg) was administered daily for 2 wk, after which the patient was allowed to rest for 21 d. Follow-up CT after one year demonstrated that the tumor had shrunk by approximately 29% after therapy. Treatment has a long stable disease benefit of more than 2.5 years. CONCLUSION These findings demonstrated that anlotinib is a promising treatment regimen for patients with TC and multiple bone metastases.

medicine, general & internal
A Single-Center Analysis of the Treatment and Prognosis of Patients with Thymic Carcinoma

Yirui Zhai,Zhouguang Hui,Wei Ji,Xiaozhen Wang,Jun Liang,Yousheng Mao,Yang Luo,Shuangmei Zou,Jima Lv,Zongmei Zhou,Dongfu Chen,Hongxing Zhang,Zefen Xiao,Luhua Wang,Qinfu Feng

DOI: https://doi.org/10.1016/j.athoracsur.2017.06.025

IF: 5.113

2017-01-01

The Annals of Thoracic Surgery

Abstract:Background. The low incidence of thymic carcinoma has precluded the development of randomized clinical trials, and present knowledge is based on small retrospective studies. We performed this single-center retrospective analysis to evaluate the clinical characteristics, treatments, and prognosis in patients with pathologically confirmed thymic carcinoma.& para;& para;Methods. Data regarding clinicopathologic characteristics, treatment protocols, toxicities, and survival were collected from 135 patients who attended our institution between January 1980 and January 2010. Survival was assessed using the Kaplan-Meier method. Univariate and multivariate analyses were performed using the log-rank test and Cox proportional hazards model.& para;& para;Results. The 135 patients (88 men) were with a median age of 48 years, and 123 patients were diagnosed with Masaoka stage III to IV disease. R0 resection was performed in 35 patients. Treatment comprised radiotherapy in 121 patients and chemotherapy in 60. The median follow-up time was 12.5 years. At 5 and 10 years, local-regional relapse free survivals were 81.4% and 54.4%, overall survivals were 42.2% and 15.4%, progression-free survivals were 29.7% and 8.0%, and distant metastasis-free survivals were 35.9% and 25.6%, respectively. R0 resection was the only independent prognosticator of overall survival, progression-free survival, and distant metastasis-free survival in univariate and multivariate analyses.& para;& para;Conclusions. Thymic carcinoma was frequently diagnosed at Masaoka stage III to IV with a poor prognosis. Surgical resection is still the predominant treatment. Radiotherapy may increase local-regional relapse free survival with mild toxicities in advanced-stage patients. (C) 2017 by The Society of Thoracic Surgeons
Postoperative radiotherapy for thymus salivary gland carcinoma: A case report

Rui Deng,Nan-Jing Li,Liang-Liang Bai,Shi-Hong Nie,Xiao-Wen Sun,Yong-Sheng Wang

DOI: https://doi.org/10.12998/wjcc.v10.i26.9484

2022-09-16

World Journal of Clinical Cases

Abstract:BACKGROUND: Salivary gland cancer is a rare disease in which cancer cells form in the tissues of the salivary glands. It mostly occurs in the glands that have secretion functions, such as the parotid gland, sublingual gland and submandibular gland. This is very rare when it occurs in other nonsecreting glands. Here, we report one case of salivary gland carcinoma occurring in the thymus and discuss related diagnoses and treatment progress.CASE SUMMARY: One 33-year-old middle-aged man presented with a thymus mass without any clinical symptoms when he underwent regular physical examination. Later, the patient was admitted to the hospital for further examination. Computed tomography (CT) showed that there was a mass of 3 cm × 2.8 cm × 1.5 cm in the thymus area. The patient had no symptom of discomfort or tumor- related medical history before. After completing the preoperative examinations, it was confirmed that the patient had indications for surgery. The surgeon performed a transthoracoscope "thymectomy + pleural mucostomy" for him. During the operation, the tumor tissue was quickly frozen, and the symptomatic section showed a malignant tumor. The final pathological result suggested thymus salivary gland carcinoma- mucoepidermoid carcinoma (MEC). In the second month after surgery, we performed local area radiotherapy for the patient, with a total radiation dose of 50.4 Gy/28Fx. After 12 mo of surgery, the patient underwent positron emission tomography-CT examination, which indicated that there was no sign of tumor recurrence or metastasis. After 16 mo of operation, CT scan re-examination showed that there was no sign of tumor recurrence or metastasis. As of the time of publication, the patient was followed up for one and a half years. He had no sign of tumor recurrence and continued to survive.CONCLUSION: The incidence of MEC in the thymus is low, and its diagnosis needs to be combined with clinical features and imaging methods. Histopathological analysis plays a key role in the diagnosis of the disease. Patients with early-stage disease have a good prognosis and long survival period. In contrast, patients with advanced-stage disease have a poor prognosis and short survival period. Combining radiotherapy and chemotherapy in inoperable patients may prolong survival.

medicine, general & internal
Case report and literature review: thyroid carcinoma showing intrathyroid thymic carcinoma

Ye Yuan,Changshu Ke,Guopeng Zhang,Jun Zhang,Qianxia Li

DOI: https://doi.org/10.3389/fonc.2022.923683

IF: 4.7

2022-08-05

Frontiers in Oncology

Abstract:Background Intrathyroid thymic carcinoma (ITTC) is a rare malignancy of the thyroid gland with histological and immunophenotypic resemblance to thymic carcinoma. Surgery combined with adjuvant radiotherapy improves the survival of patients with ITTC. However, for patients with extensive metastases, there is currently no effective treatment. Chemotherapy is an option but has not demonstrated improved patient survival. Methods and results A female patient presented with metastases to the pleura, lung, and bone 16 years after surgery for ITTC. As radiotherapy and chemotherapy failed to control the recurrent disease, lenvatinib treatment was initiated. After 3 months, positron emission tomography/computed tomography showed a substantial reduction of all metastatic lesions and decreased tumor metabolism. The patient continues to receive lenvatinib and remains well and symptom-free. Conclusion For patients with ITTC who have progressive, life-threatening metastases, lenvatinib represents a valuable salvage therapy that may offer a sustained reduction in tumor burden and maintenance of quality of life.

oncology
Carcinoma showing thymus-like element of the thyroid:a clinicopathological observation

PAN Yu-lin,XIE Yun

2007-01-01

Abstract:Objective To investigate the clinical-pathological features of carcinoma showing thymus-like differentiation(CASTLE) of the thyroid. Methods This rare case of CASTLE was studied for histomorphology and immunohistochemical features with review of the related literature. Results Macroscopically,the tumor showed a solid gray-white mass and was separated into lobules by fibrous tissues,mature lymphocytes and plasma cells infiltration in the fibrous septum.The tumor cells were polygonal to spindle in shape,vesicular nucleus,distinct nucleoli and scattered squamous pattern of differentiation.The tumor stained positively for CD5 and CD117. Conclusion Carcinoma showing thymus-like differentiation is a rare malignancy that occurs in the soft tissues of the neck or in the thyroid gland.It needs to be distinguished from undifferentiated thyroid carcinoma,squamous cell thyroid carcinoma,lymphoepithelioma-like carcinoma.Immunohistochemical staining for CD5 and CD117 is helpful in confirming the diagnosis.
Long-Term Survival After Surgical Treatment of Thymic Carcinoma: A Retrospective Analysis from the Chinese Alliance for Research of Thymoma Database

Hao Fu,Zhi-Tao Gu,Wen-Tao Fang,Jian-Hua Fu,Yi Shen,Yong-Tao Han,Zhen-Tao Yu,Yin Li,Li-Jie Tan,Lie-Wen Pang,Ke-Neng Chen

DOI: https://doi.org/10.1245/s10434-015-4825-4

IF: 4.339

2015-01-01

Annals of Surgical Oncology

Abstract:Background Thymic carcinoma is a type of rare and highly malignant tumor that originates from the thymic epithelium. Treatment and prognosis of thymic carcinoma remain controversial. We retrospectively analyzed survival data from a large-sample multicenter database in China. Methods The Chinese Alliance for Research of Thymoma constructed a retrospective database of patients with thymic epithelial tumors, which enrolled 1930 patients from January 1996 to August 2013, including 329 with thymic carcinomas. In this study, we analyzed clinical, pathologic, and treatment information, measured long-term survival rates, and identified relevant prognostic factors. Results Of 329 patients, R0 resection was performed in 211 (57.7 %), R1 in 34 (9.2 %), and R2 in 84 (22.5 %). The 3-, 5-, and 10-year survival rates were 78.3, 67.1, and 47.9 %, respectively. In univariate analysis, early Masaoka-Koga stage, R0 resection, and postoperative radiotherapy were associated with better overall survival. Early Masaoka-Koga stage and postoperative radiotherapy were also associated with disease-free survival. In multivariate analyses, R0 resection, Masaoka-Koga stage, and postoperative radiotherapy were significant prognostic factors of survival. Conclusions Complete resection is the preferred primary treatment for thymic carcinoma. R0 resection, early Masaoka-Koga stage, and postoperative radiotherapy are significant predictors of improved survival.
Clinical Pathology Analysis of Primary Squamous Cell Carcinoma of the Thyroid

HU Zhi-xiong,WANG Hai,WU Bo,ZHOU Hang-bo,ZHANG Ru-song,JIANG Shao-jun,LU Zhen-feng,ZHOU Xiao-jun

DOI: https://doi.org/10.16073/j.cnki.cjcpt.2010.23.016

2010-01-01

Abstract:OBJECTIVE:To investigate the clinical-pathological characteristics,diagnosis and differential diagnosis of primary squamous cell carcinoma of thyroid.METHODS: The clinical-pathological information was retrospectively reviewed in 5 cases of the tumor.The pathological characteristics were studied with HE,immunohistochemical stains and electron microscopy.RESULTS: Three of 5 cases of primary squamous cell carcinoma of thyroid were female,the mean age was 55 years old,and the average survival was 3-7 months after operation.The main symptoms were trachelophyma,dyspnea,hoarseness and dysphagia.Microscopically,the differentiation degree of squamous cell carcinoma of thyroid was Degree Ⅰ.Extensive infiltration of the peri-thyroidal soft tissue by squamous cell carcinoma was its characteristic.All the cases typically presented positivity for CKpan and CK19.The positive rate of Ki-67 expression was 30%-50%.TTF-1,TG and CD5 were absent in all the cases.Ultrastructure showed that the cells of tumors were heteromorphism,tonofibril in intracytoplasm,and well-developed desmosome between the cells.CONCLUSIONS: Primary squamous cell carcinoma of the thyroid is a rare type of thyroid carcinoma,but highly aggressive.Secondary squamous cell carcinoma and squamous metaplasia of other type of thyroid lesion should be excluded before diagnosis.
The evaluation of evidence relating to traces of cocaine on banknotes.

Amy Wilson,C. Aitken,R. Sleeman,J. Carter

DOI: https://doi.org/10.1016/j.forsciint.2013.11.011

IF: 2.676

2014-03-01

Forensic Science International

Abstract:
Ultrasonic recording of circulation rate and muscular and heart-valve motion

L. I. Yakimenkov,V. F. Kobzev,N. A. Kostrov

DOI: https://doi.org/10.1007/BF00572972

1968-07-01

Biomedical Engineering

Abstract:
A rare case of thyroid carcinosarcoma arising from recurrent papillary thyroid cancer: Case report and review of the literature

Yuzhang Gao,Yaoyun Tang,Xin Zhang,Ping Wu

DOI: https://doi.org/10.1016/j.oraloncology.2024.106694

IF: 5.972

2024-01-25

Oral Oncology

Abstract:Background Thyroid carcinosarcoma represents a rare subtype of thyroid cancer, distinguished by its unique histopathology-simultaneous malignant epithelial and mesenchymal cells. The occurrence of thyroid carcinosarcoma arising from recurrent papillary thyroid cancer is exceptionally infrequent. Methods Study outlines a patient's thyroid carcinosarcoma journey, covering presentation, recurrence, diagnostics, surgeries, and follow-up. A PubMed search gathered data on pathological features and treatment approaches for thyroid carcinosarcoma. Results The patient initially diagnosed with papillary thyroid cancer underwent thyroidectomy, neck dissection, and radioactive iodine therapy. Recurrence revealed thyroid carcinosarcoma, featuring papillary carcinoma, squamous cell carcinoma, and spindle cell components. Total laryngectomy followed by adjuvant radiotherapy and chemotherapy. The patient was followed for 17 months with no evidence of disease. Conclusions This extraordinary case exemplifies a rare instance of local relapse in form of thyroid carcinosarcoma following an initial diagnosis of papillary thyroid carcinoma. Surgical resection and chemoradiotherapy show promising outcomes in managing this challenging condition.

dentistry, oral surgery & medicine,oncology

Left Caputo fractional ‖⋅‖∞-Landau inequalities

Primary Leiomyosarcoma of the Thyroid Gland: A Rare Case Report and Literature Review

[Carcinoma Showing Thymus-Like Differentiation of the Thyroid: a Study of 2 Cases].

Primary Small Cell Cancer of Cervical Trachea: A Case Report and Literature Review

The Rate of Bromate Decomposition in the Simulated Human Stomach and Associated Studies

Diagnosis of medial tubercle fractures of the talar posterior process using oblique views.

Structure of testicular angiotensin-converting enzyme. A segmental mosaic isozyme.

[Six cases of thymic carcinoma: a clinical review]

A basaloid carcinoma with multilocular thymic cyst mimicking a mediastinal teratoma

About thymic carcinomas: challenges in diagnosis and management

Thymic carcinoid with multiple bone metastases: A case report

A Single-Center Analysis of the Treatment and Prognosis of Patients with Thymic Carcinoma

Postoperative radiotherapy for thymus salivary gland carcinoma: A case report

Case report and literature review: thyroid carcinoma showing intrathyroid thymic carcinoma

Carcinoma showing thymus-like element of the thyroid:a clinicopathological observation

Long-Term Survival After Surgical Treatment of Thymic Carcinoma: A Retrospective Analysis from the Chinese Alliance for Research of Thymoma Database

Clinical Pathology Analysis of Primary Squamous Cell Carcinoma of the Thyroid

The evaluation of evidence relating to traces of cocaine on banknotes.

Ultrasonic recording of circulation rate and muscular and heart-valve motion

A rare case of thyroid carcinosarcoma arising from recurrent papillary thyroid cancer: Case report and review of the literature